Wikipedia -WSS

Wikipedia

author：Wikipedia 2025-09-06 01:58:54 - browse：81

A product image of the Cue reader COVID-19 home use test — Businesswire via AP

The Food and Drug Administration warned consumers Monday to not use Cue Health’s at-home Covid-19 tests. This follows an FDA warning letter to the company last week that said Cue was not following the conditions stipulated in the emergency use authorizations for its tests.

The FDA letters said the tests could give false results. Specifically, the agency said that the company had changed how the electrochemical signals within the test device were generated, received, and interpreted — changes the FDA has not authorized. These changes decreased the stability of the tests and might lead to false results, the agency said.

The FDA warnings come near what might be the end of a spectacularly bumpy ride for the company. When Cue went public in 2021, it was valued at nearly $3 billion. It supplied tests for the NBA’s 2020 “bubble,” leading a Trump administration official to proclaim that if the test was “good enough for LeBron,” the administration would bring it to the American people — and it did, in a $481 million deal.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Readout LOUD podcast: mifepristone case, GLP

WSS

Using force crossed my mind when examining a defiant young patient

Eliminate the waiting period for sterilization covered by Medicaid

Readout Newsletter: Blackstone Life Sciences, Merck, Bluebird Bio

Primary care physicians play key roles in Alzheimer's management

CDC advisory group OKs chikungunya vaccine

Will generative AI in health care meet the fate of IBM's Dr. Watson?

focus

Wikipedia

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

entertainment

Medical leaders decry Supreme Court decision on affirmative action

Elisabeth Bik tackles the widespread issue of research misconduct

Medicare details structure of new drug price negotiation program

Eliminate the waiting period for sterilization covered by Medicaid

The cancer drug shortage isn’t new — and neither are the solutions

Scientists boost immune system in aging mice by making it youthful

New air purifier tech could be key to improving indoor air quality

Readout LOUD podcast: mifepristone case, GLP

What does generative AI mean for health care? We asked experts

Oprah kicked off a national conversation on obesity. Let's have it

hotspot

Doctor of U.S. President Joe Biden says he is fit for duty

Readout Newsletter: Merck, Vertex, and Viking updates

CDC panel: People 65 and older should get a Covid spring booster shot

Redefining sustainability for the pharmaceutical industry

Why the world’s most expensive drug might be worth the price

Mifepristone protocols being wielded by pill's opponents in Supreme Court case

hotspot

explore

Wikipedia

focus